• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人物角色的遗传性血管性水肿的以人为本的创新方法。

A human centred innovative approach based on persona in hereditary angioedema.

机构信息

HAE Unit, IRCCS Istituti Clinici Scientifici Maugeri, Via Camaldoli 64, 20138, Milan, Italy.

Your Business Partner, London, UK.

出版信息

Orphanet J Rare Dis. 2024 Aug 10;19(1):291. doi: 10.1186/s13023-024-03302-x.

DOI:10.1186/s13023-024-03302-x
PMID:39127675
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11316298/
Abstract

BACKGROUND

Hereditary Angioedema (HAE) due to C1-inhibitor deficiency (C1INH) is a rare condition, clinically characterised by recurrent swelling. The unpredictability of attacks affects the patients' quality of life (QoL). HAE patients and their families have vast unmet physical, psychological, and social needs. A human-centred design (HCD) approach to describing the needs of different user types is to utilise personas, a data-driven narrative tool for communicating user archetypes that capture the individuals' attitudes, goals, and behaviours. The aim of this study was to create and analyse personas based on HAE patients' and their caregivers' interviews. Semi-structured interviews were conducted through anthropological conversations with patients, patient-caregivers (double role of patient and caregiver), and non-affected caregivers. Qualitative and quantitative insights from analyses formed the basis to create personas.

RESULTS

We enrolled 17 subjects: 15 patients (6 of them were patient-caregivers) and 2 non-affected caregivers. The mean age of participants was 50.3 ± 14.4 years. Eight patients were on treatment with prophylactic therapy. The mean percentage score of Angioedema Quality of Life (AE-QoL) for HAE patients was 19.8 ± 12.0. Six personas were identified describing the participants' personal history, disease management, and needs: four personas referred to patients, one to patient-caregivers, and one non-affected caregiver personas were identified. Across patient personas, the most expressed needs were psychological support and better awareness amongst healthcare professionals. Caregivers, on their side, desired better information about the disease, including the latest therapies, and higher awareness within the community.

CONCLUSION

A Human Centred Innovative Approach Based on Persona extends beyond the physical symptoms to encompass the psychological and social aspects of the individual's well-being also including the family in the evaluation.

摘要

背景

由于 C1 抑制剂缺乏(C1INH)导致的遗传性血管性水肿(HAE)是一种罕见的疾病,其临床特征为反复发作的肿胀。发作的不可预测性影响了患者的生活质量(QoL)。HAE 患者及其家属存在广泛的未满足的身体、心理和社会需求。一种以人为中心的设计(HCD)方法来描述不同用户类型的需求是利用人物角色,这是一种数据驱动的叙事工具,用于传达捕获个人态度、目标和行为的用户原型。本研究的目的是基于 HAE 患者及其护理人员的访谈创建和分析人物角色。通过与患者、患者护理人员(患者和护理人员的双重角色)和非患者护理人员进行人类学对话进行半结构化访谈。分析中的定性和定量见解为创建人物角色提供了基础。

结果

我们招募了 17 名参与者:15 名患者(其中 6 名是患者护理人员)和 2 名非患者护理人员。参与者的平均年龄为 50.3±14.4 岁。8 名患者接受预防性治疗。HAE 患者的血管性水肿生活质量(AE-QoL)平均百分比评分为 19.8±12.0。确定了 6 个人物角色来描述参与者的个人历史、疾病管理和需求:4 个人物角色涉及患者,1 个人物角色涉及患者护理人员,1 个非患者护理人员角色。在患者人物角色中,最表达的需求是心理支持和提高医疗保健专业人员的认识。另一方面,护理人员希望更好地了解疾病,包括最新的治疗方法,并提高社区内的认识。

结论

基于人物角色的以人为本的创新方法不仅涵盖了个人幸福感的身体症状,还涵盖了心理和社会方面,还包括在评估中纳入家庭。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ff/11316298/5b91b78f08c7/13023_2024_3302_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ff/11316298/5b91b78f08c7/13023_2024_3302_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ff/11316298/5b91b78f08c7/13023_2024_3302_Fig1_HTML.jpg

相似文献

1
A human centred innovative approach based on persona in hereditary angioedema.基于人物角色的遗传性血管性水肿的以人为本的创新方法。
Orphanet J Rare Dis. 2024 Aug 10;19(1):291. doi: 10.1186/s13023-024-03302-x.
2
Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study.评估成人遗传性血管性水肿急性发作症状严重程度的视觉模拟评分的内容效度:一项访谈研究。
Patient. 2012;5(2):113-26. doi: 10.2165/11597490-000000000-00000.
3
Hereditary angioedema in Spain: medical care and patient journey.西班牙遗传性血管性水肿:医疗护理和患者就医流程。
Orphanet J Rare Dis. 2024 May 21;19(1):210. doi: 10.1186/s13023-024-03182-1.
4
Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema.通过遗传性血管性水肿患者的系统化管理方案减少发作次数和提高生活质量。
Int Arch Allergy Immunol. 2021;182(8):697-708. doi: 10.1159/000513896. Epub 2021 Mar 3.
5
Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project.遗传性血管性水肿患者生活质量问卷的制定:西班牙多中心研究项目(HAE-QoL)。
Health Qual Life Outcomes. 2012 Jul 20;10:82. doi: 10.1186/1477-7525-10-82.
6
Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study.安全性、有效性及对遗传性血管性水肿患者生活质量影响的自我给药血浆源性纳米过滤 C1 抑制剂(Berinert®):SABHA 研究。
Orphanet J Rare Dis. 2018 Apr 10;13(1):51. doi: 10.1186/s13023-018-0797-3.
7
Preventive Treatment of Hereditary Angioedema: A Review of Phase III Clinical Trial Data for Subcutaneous C1 Inhibitor and Relevance for Patient Management.遗传性血管性水肿的预防性治疗:皮下注射C1抑制剂的III期临床试验数据综述及其对患者管理的意义。
Clin Ther. 2021 Dec;43(12):2154-2166.e1. doi: 10.1016/j.clinthera.2021.10.008. Epub 2021 Dec 5.
8
The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.认识和管理一种罕见的血管性水肿的重要性:C1 抑制剂缺乏引起的遗传性血管性水肿。
Postgrad Med. 2021 Aug;133(6):639-650. doi: 10.1080/00325481.2021.1905364. Epub 2021 Jul 6.
9
Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.用于观察性研究中遗传性血管性水肿评估的患者报告结局问卷的开发与内容效度测试
Health Qual Life Outcomes. 2015 Jul 1;13:92. doi: 10.1186/s12955-015-0292-7.
10
Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.遗传性血管性水肿的临床表现、诊断与治疗:来自日本94位医生的调查数据
Ann Allergy Asthma Immunol. 2015 Jun;114(6):492-8. doi: 10.1016/j.anai.2015.03.010. Epub 2015 Apr 11.

本文引用的文献

1
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus.血管性水肿的定义、缩略语、命名和分类(DANCE):美国过敏、哮喘和免疫学学会,美国过敏、哮喘和临床免疫学会,加拿大过敏、哮喘和临床免疫学会,亚太过敏、哮喘和临床免疫学会共识。
J Allergy Clin Immunol. 2024 Aug;154(2):398-411.e1. doi: 10.1016/j.jaci.2024.03.024. Epub 2024 Apr 25.
2
13th C1-inhibitor deficiency and angioedema workshop-2023 : Edited by: Róbert Hohol; Lectored by: Henriette Farkas, Lilian Varga; Cover artwork: Gergely Hosszú.2023年第13届C1抑制剂缺乏症与血管性水肿研讨会:编辑:罗伯特·霍霍尔;演讲者:亨丽埃特·法尔卡斯、莉莲·瓦尔加;封面插图:盖尔盖利·霍苏
Allergy Asthma Clin Immunol. 2023 Dec 20;19(Suppl 1):106. doi: 10.1186/s13223-023-00845-9.
3
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.《遗传性血管性水肿管理的国际 WAO/EAACI 指南-2021 年修订版》。
Allergy. 2022 Jul;77(7):1961-1990. doi: 10.1111/all.15214. Epub 2022 Feb 3.
4
Setting meaningful goals in rehabilitation: A qualitative study on the experiences of clients and clinicians in working with a practical tool.设定康复治疗中的有意义目标:一项关于客户和临床医生使用实用工具的经验的定性研究。
Clin Rehabil. 2022 Mar;36(3):415-428. doi: 10.1177/02692155211046463. Epub 2021 Nov 3.
5
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.拉那芦单抗长期预防遗传性血管性水肿发作的疗效:HELP OLE 研究。
Allergy. 2022 Mar;77(3):979-990. doi: 10.1111/all.15011. Epub 2021 Aug 13.
6
Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy.倾听患者心声:一项基于深入定性研究的调查,探究皮下注射C1抑制剂替代疗法治疗的遗传性血管性水肿真实世界患者中与健康相关生活质量相关的因素。
Allergy Asthma Clin Immunol. 2021 Jun 27;17(1):60. doi: 10.1186/s13223-021-00550-5.
7
Analysis of Heart-Rate Variability during Angioedema Attacks in Patients with Hereditary C1-Inhibitor Deficiency.遗传性 C1 抑制剂缺乏症患者血管性水肿发作时心率变异性分析。
Int J Environ Res Public Health. 2021 Mar 12;18(6):2900. doi: 10.3390/ijerph18062900.
8
How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?血管性水肿生活质量问卷如何帮助医生治疗 C1 抑制剂缺乏症患者?
Clin Rev Allergy Immunol. 2021 Aug;61(1):50-59. doi: 10.1007/s12016-021-08850-9. Epub 2021 Mar 3.
9
Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema.通过遗传性血管性水肿患者的系统化管理方案减少发作次数和提高生活质量。
Int Arch Allergy Immunol. 2021;182(8):697-708. doi: 10.1159/000513896. Epub 2021 Mar 3.
10
Short bowel syndrome and the impact on patients and their families: a qualitative study.短肠综合征及其对患者及其家庭的影响:一项定性研究。
J Hum Nutr Diet. 2020 Dec;33(6):767-774. doi: 10.1111/jhn.12803. Epub 2020 Aug 10.